HEPTINSTALL S, 2017. Platelets. 28(1), 103-105
BATH PM, APPLETON JP, BERIDZE M, CHRISTENSEN H, DINEEN RA, DULEY L, ENGLAND TJ, HEPTINSTALL S, JAMES M, KRISHNAN K, MARKUS HS, POCOCK S, RANTA A, ROBINSON TG, FLAHERTY K, SCUTT P, VENABLES GS, WOODHOUSE LJ and SPRIGG N, 2016. International journal of stroke : official journal of the International Stroke Society. (In Press.)
HEPTINSTALL S, 2016. Platelets. 27(6), 495
ALGAHTANI M and HEPTINSTALL S, 2016. Future cardiology. 13(1), 33-47
KEELER BD, SIMPSON JA, FOX SC, STAVROU CL, BRIGGS RA, PATEL P, HEPTINSTALL S and ACHESON AG, 2015. International journal of surgery (London, England). 17, 28-33
KRISHNAN K, BERIDZE M, CHRISTENSEN H, DINEEN R, DULEY L, HEPTINSTALL S, JAMES M, MARKUS HS, POCOCK S, RANTA A, ROBINSON T, NIKOLA N, VENABLES G and BATH P, 2015. International journal of stroke : official journal of the International Stroke Society. 10(7), 1159-65
DOVLATOVA N, LORDKIPANIDZ脡 M, LOWE GC, DAWOOD B, MAY J, HEPTINSTALL S, WATSON SP, FOX SC and THE UK GAPP STUDY GROUP, 2014. Journal of thrombosis and haemostasis : JTH. (In Press.)
THOMAS MR, WIJEYERATNE YD, MAY JA, JOHNSON A, HEPTINSTALL S and FOX SC, 2014. Platelets. (In Press.)
GLENN JR, DOVLATOVA N, WHITE AE, DHILLON K, HEPTINSTALL S and FOX SC, 2014. Thrombosis and haemostasis. 111(3), 539-48
HEPTINSTALL, S, 2013. . In: FERRO, A and GARCIA, DA, eds., Antiplatelet and Anticoagulation Therapy Springer. 1-44
FOX SC, MAY JA, JOHNSON A, HERMANN D, STRIETER D, HARTMAN D and HEPTINSTALL S, 2013. Platelets. 24(5), 392-400
HEPTINSTALL S, 2013. Thrombosis and haemostasis. 110(6), 1108-9
IY脷, D., GLENN, J.R., WHITE, A.E., JOHNSON, A., HEPTINSTALL, S. and FOX, S.C., 2012. Thrombosis and Haemostasis. 107(4), 797-799
GLENN JR, WHITE AE, IYU D and HEPTINSTALL S, 2012. Platelets. 23(5), 344-51
WIJEYERATNE YD, JOSHI R and HEPTINSTALL S, 2012. Clinical Pharmacology (Expert review). 5(3), 257-269
HEPTINSTALL S, 2012. Arteriosclerosis, thrombosis, and vascular biology. 32(8), 1751-2
WIJEYERATNE YD, JOSHI R and HEPTINSTALL S, 2012. Expert review of clinical pharmacology. 5(3), 257-69
IYU, D., GLENN, J.R., WHITE, A.E., FOX, S.C. and HEPTINSTALL, S., 2011. Arteriosclerosis, Thrombosis and Vascular Biology. 31(2), 416-422
IY脷, D., J脺TTNER, M., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2011. Prostaglandins and Other Lipid Mediators. 94(1-2), 9-16
IY脷, D., GLENN, J.R., WHITE, A.E., FOX, S.C., GIEZEN, H. VAN, NYLANDER, S. and HEPTINSTALL, S., 2011. Thrombosis and Haemostasis. 105(1), 96-106
IY脷 D, GLENN JR, WHITE AE, FOX SC, DOVLATOVA N and HEPTINSTALL S, 2011. Platelets. 22(7), 504-15
WIJEYERATNE YD and HEPTINSTALL S, 2011. British Journal Of Clinical Pharmacology. 72(4), 647-57
IYU, D., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2010. Platelets. 21(5), 329-342
HEPTINSTALL S, SPAULDING C, DANSER J, HALVORSEN S, JAMES S, TUOMILEHTO J, HOHNLOSER S, LEF脠VRE T, CARMELIET P and GITTENBERGER-DE GROOT AC, 2010. Photofeature: European cardiovascular researchers on holiday and outside of work Circulation. 122(7), f40-f42
MAHAJAN R and HEPTINSTALL S, 2010. Should critical care patients receive or remain on treatment with antiplatelet drugs? Critical Care Medicine. 38(1), 298-300
SAMAMA MM, KUNITADA S, OURSIN A, DEPASSE F and HEPTINSTALL S, 2010. Thrombosis Research. 126(4), e286-293
FOX SC, MAY JA, SHAH A, NEUBERT U and HEPTINSTALL S, 2009. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets. 20(4), 250-9
HEPTINSTALL, S., FOX, S.C., MAY, J.A., HERMANN, D., STREITER, D. and HARTMAN, D., 2009. Journal of Thrombosis and Haemostasis. 7(Supplement 2), OC-MO-100
DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, L., RALEVIC, V. and HEPTINSTALL, S., 2009. Detection of P2Y14 receptor protein on platelets and investigation of the role of P2Y14 in platelet function. J Thromb Haemostas. Supplement 2, WE-045
FOX, S.C., MAY, J.A., SHAH, A., NEUBERT, U. and HEPTINSTALL, S., 2009. Assessment of clopidogrel and aspirin therapy using remote platelet testing. J Thromb Haemostas. 7(Supplement 2), WE-755
IYU, D and HEPTINSTALL, S., 2009. Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade. J Thromb Haemost. 7(Supplement 2), MO-101
STOREY, ROBERT F, MELISSA THORNTON, S, LAWRANCE, RACHAEL, HUSTED, STEEN, WICKENS, MARK, EMANUELSSON, H脜KAN, CANNON, CHRISTOPHER P, HEPTINSTALL, STAN and ARMSTRONG, MARTIN, 2009. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets. 20(5), 341-8
VISIOLI, FRANCESCO, BERNAERT, HERWIG, CORTI, ROBERTO, FERRI, CLAUDIO, HEPTINSTALL, STAN, MOLINARI, ENRICO, POLI, ANDREA, SERAFINI, MAURO, SMIT, HENK J, VINSON, JOE A, VIOLI, FRANCESCO and PAOLETTI, RODOL, 2009. Chocolate, lifestyle, and health. Critical Reviews in Food Science and Nutrition. 49(4), 299-312
HEPTINSTALL S, IYU D, MANOLOPOULOS P, GLENN JR, WHITE AE, JOHNSON A, DOVLATOVA N, FOX SC, MAY JA, HERMANN D and MAGNUSSON O, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
MAY JA, FOX SC, GLENN JR, CRAXFORD S and HEPTINSTALL S, 2008. Platelet function reduces significantly during the morning. Platelets. 19(7), 556-8
MANOLOPOULOS, P., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N.L., TANG, S.-W., THOMAS, N.R., RALEVIC, V. and HEPTINSTALL, S., 2008. Platelets. 19(2), 134-145
GLENN JR, WHITE AE, JOHNSON AJ, FOX SC, MYERS B and HEPTINSTALL S, 2008. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1), 59-69
JOHNSON, A, DOVLATOVA, N and AND HEPTINSTALL, H., 2008. Thrombosis and Haemostasis. 99(6), 1127-1129
DOVLATOVA, N.L., JAKUBOWSKI, J.A., SUGIDACHI, A. and HEPTINSTALL, S., 2008. Journal of Thrombosis and Haemostasis. 6(7), 1153-1159
DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, M.L., RALEVIC, V. and HEPTINSTALL, S., 2008. Thrombosis and Haemostasis. 100(2), 261-270
DOVLATOVA N, WIJEYERATNE YD, FOX SC, MANOLOPOULOS P, JOHNSON AJ, WHITE AE, LATIF ML, RALEVIC V and HEPTINSTALL S, 2008. Thrombosis and haemostasis. 100(2), 261-70
JOHNSON A, DOVLATOVA N and HEPTINSTALL S, 2008. Thrombosis and haemostasis. 99(6), 1127-9
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78
WHITE AE, GLENN JR, FOX SC, JOHNSON A, MYERS B and HEPTINSTALL S, 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100
FOX SC, MAY JA and HEPTINSTALL S, 2007. Quantitation of endothelial microparticles in plasma samples is impaired by chylomicrons following ingestion of a fatty meal Platelets. 18(1), 85-86
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
XAVIER, R, WHITE, A, FOX, S, WILCOX, R and AND HEPTINSTALL, S., 2007. Thrombosis and Haemostasis. 98(6), 1266-1275
FOX, S.C, MAY, J.A and AND HEPTINSTALL, S., 2007. Measurement of endothelial microparticles in blood is impaired if chylomicrons are present after a fatty meal. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-526
MAY, J.A, FOX, S.C, HEPTINSTALL, S and AND KWIK-URIBE, C., 2007. Effects of a flavanol-rich cocoa beverage on platelet and leucocyte function in man. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-T-685
XAVIER, R, WHITE, A, FOX, S and AND HEPTINSTALL, S., 2007. Platelet aggregation is enhanced under conditions of hypothermia. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-320
STOREY, R.F, HUSTED, S, HARRINGTON, R.A, HEPTINSTALL, S, WILCOX, R.G, PETERS, G, WICKENS, M, EMANUELSSON, H, GURBEL, P, GRANDE, P and AND CANNON, C.P., 2007. Journal of the American College of Cardiology. 50(19), 1852-1856 (In Press.)
WIJEYERATNE, Y.D, WHITE, A.E, RALEVIC, V and AND HEPTINSTALL, S., 2007. Comparison of the effects of the P2Y14 receptor agonist UDP-glucose and the EP3 receptor agonist sulprostone on platelet function. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-280
XAVIER RG, WHITE AE, FOX SC, WILCOX RG and HEPTINSTALL S, 2007. Thrombosis and haemostasis. 98(6), 1266-75
WIRE, R, MAY, J.A, HEPTINSTALL, S, CHEN, D, LU,Y and AND ZHAO, L., 2007. Heteroclitin D, A component of plants of the Kadsura species inhibits paf-induced platelet aggregation, P-selectin expression and platelet-leucocyte conjugate formation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-344
DOVLATOVA, N.L, JAKUBOWSKI, J.A, SUGIDACHI, A and AND HEPTINSTALL, S., 2007. Competition between reversible and irreversible P2Y12 antagonists and its influence on ADP-mediated platelet activation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-340
STOREY, R., HARRINGTON, R, A., HUSTED, S., HEPTINSTALL, S., WILCOX, R., GURBEL, A., GRANDE, P., WICKENS, M., PETERS, G., EMANUELSSON, H. and CANNON, C., 2007. AZD6140 Suppresses Platelet Aggregation in Clopidogrel-Treated Patients Even in Those With High Aggregation Levels JACC. 49(9 (Supplement A)),
HEPTINSTALL, S, ANDERS, R, GURNEY, M, HERMANN, D and AND HARTMAN, D., 2007. EP3 receptors - a new target for inhibition of platelet aggregation and platelet-leucocyte conjugate formation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-273
HEPTINSTALL, S, ANDERS, R, GURNEY, M, HERMANN, D and AND HARTMAN, D., 2007. EP3 Receptors: A new target for inhibition of platelet function in inflammatory thrombotic disease. Arteriosclerosis Thrombosis and Vascular Biology. 27(e109),
STOREY RF, HUSTED S, HARRINGTON RA, HEPTINSTALL S, WILCOX RG, PETERS G, WICKENS M, EMANUELSSON H, GURBEL P, GRANDE P and CANNON CP, 2007. Journal of the American College of Cardiology. 50(19), 1852-6
MANOLOPOULOS, P, IYU ESPINOSA, D, ANDERS, B, GURNEY, M, HERMANN, D, HARTMAN, D and AND HEPTINSTALL, S., 2007. Platelet EP3 receptors as targets for antithrombotic agents - comparison of DG-041 with aspirin and AR-C69931. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-345
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3
HEPTINSTALL S, MAY JA, FOX SC, KWIK-URIBE C and ZHAO L, 2006. Journal of cardiovascular pharmacology. 47 Suppl 2, S197-205; discussion S206-9
ZHAO, LIAN, GRAY, LAURA, LEONARDI-BEE, JO, WEAVER, CHRIS S, HEPTINSTALL, STAN and BATH, PHILIP M W, 2006. Platelets. 17(2), 100-4
HUSTED, S., EMANUELSSON, H., HEPTINSTALL, S., SANDSET, P.M., WICKENS, M. and PETERS, G., 2006. European Heart Journal. 27(9), 1038-1047
HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
STOREY R.F., HUSTED S, HARRINGTON R.A., HEPTINSTALL S., WILCOX R.G. and ET AL., 2006. AZD6140 Yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. In: 204 (A821)
HEPTINSTALL, S, 2006. Journal of Thrombosis and Haemostasis: JTH. 4(3), 539-41
GLENN JR, WHITE AE, JOHNSON AJ, FOX SC, BEHAN MW, DOLAN G and HEPTINSTALL S, 2005. Platelets. 16(3-4), 159-70
STOREY RF, MAY JA and HEPTINSTALL S, 2005. Thrombosis Research. VOL 115(NUMBER 4), 301-307
BEHAN MW, FOX SC, HEPTINSTALL S and STOREY RF, 2005. Platelets. 16(2), 73-80
HEPTINSTALL, S., JOHNSON, A., GLENN, J.R. and WHITE, A.E., 2005. Journal of Thrombosis and Haemostasis. 3(10), 2331-2339
HEPTINSTALL,S., TANG,S., MANOLOPOULOS,P., FOX,S., MAY,J., GLENN,J. and RALEVIC,V., 2005. Derivatives of coenzymes A inhibit platelet aggregation via efects at P2Y1 and P2Y12 receptors. In: 20th Congress of the International Society on Thrombosis & Haemostasis. OR334
ZHAO, L., SPRIGG, N., HEPTINSTALL, S. and BATH, P., 2005. Effects of granulocyte-colony stimulating factor on platelets and leukocyte function in whole blood in vitro. In: International Society of Thrombosis & Haemostasis. P02373
FOX, S.C., MANOLOPOULOS, P., MAY, J.A. and HEPTINSTALL, S., 2005. Platelet aggregation, microparticle formation and platelet-leukocyte conjugate formation induced by combinations of 5-HT and epinephrine are inhibited by Sarpogrelate and BP-984 In: International Society Thrombosis & Haemostasis, Sydney, Australia. PO2149
MAY, J., ZHAO, L. and HEPTINSTALL, S., 2005. Dietary flavanols - Effects on platelets and leukocytes. In: International Society of Thrombosis & Haemostasis. PO953
BATH, P.M.W., ZHAO, L. and HEPTINSTALL, S., 2005. European Heart Journal supplements. 7(Supplement C), C12-18
MANOLOPOULOS, P., FOX, S.C. and HEPTINSTALL, S., 2005. Involvement of P2Y1 and P2Y12 receptors in platelet responses to adenosine diphosphate and thrombin receptor activating peptide. In: International Society of Thrombosis & Haemostasis, Sydney 2005. PO1498
STOREY, ROBERT F, MAY, JANE A and HEPTINSTALL, STAN, 2005. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Thrombosis Research. 115(4), 301-7
HEPTINSTALL, S., 2005. The recent history of platelets in thrombosis and other disorders.. In: Wellcome Witnesses to the Twentieth Century Medicine 23.
FOX, S.C., BEHAN, M.W.H and HEPTINSTALL, S., 2004. Cell Calcium. 35(1), 39-46
FOX SC, SASAE R, JANSON S, MAY JA and HEPTINSTALL S, 2004. Platelets. 15(2), 85-93
HEPTINSTALL S, TANG SW, MANOLOPOULOS P, FOX SC, MAY J, GLENN J, RALEVIC V., 2004. N0204-003 inhibits ADP-induced platelet function via antagonism at P2Y1 and In: Platelets. 493
FOX SC, SIEBERT D, MCMAHON A, MAY J, SPANGENBERG P, HEPTINSTALL S, 2004. Inhibitory effect of physical exercise on platelet aggregation in whole blood may be through In: Platelets. 490
FOX SC, MAY JA, MANOLOPOULOS P, HEPTINSTALL S, 2004. P2Y1 and P2Y12 purinergic receptor involvement in platelet responses induced by collagen and TRAP In: Platelets. 364
FOX SC, MAY JA, MANOLOPOULOS P, HEPTINSTALL S, 2004. P2Y1 and P2Y12 purinergic receptor involvement in platelet responses induced by collagen and TRAP In: Platelets. 364
MANOLOPOULOS P, FOX SC, HEPTINSTALL S., 2004. Involvement of P2Y1 and P2Y12 purinergic receptors in platelet responses to the combination of Adenosine Diphosphate and Thrombin Receptor Activating Peptide In: Platelets. 502
FOX SC, MANOLOPOULOS P, MAY J, HEPTINSTALL S, 2004. Studies on the effects of sarpogrelate and its active metabolite BP-984 on 5-HT-induced platelet activation In: Platelets. 490
ZHAO, LIAN, BATH, PHILIP, L脙露SCHE, WOLFGANG and HEPTINSTALL, STAN, 2004. Platelet-monocyte interaction and GPIIb/IIIa blockade. Thrombosis and Haemostasis. 92(4), 888-90
ZHAO, L., BATH, P.M., MAY, J., LOSCHE, W. and HEPTINSTALL, S., 2004. Platelets. 15, 63-63
HEPTINSTALL, STAN, GLENN, JACKIE R, MAY, JANE A, STOREY, ROBERT F and WILCOX, ROBERT G, 2004. Catheterization and Cardiovascular Interventions. 63(3), 397-8
WILLMOT, MARK, ZHAO, LIAN, HEPTINSTALL, STAN and BATH, PHILIP, 2004. Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 13(3), 138-40
ZHAO, LIAN, BATH, PHILIP M W, MAY, JANE, L脙茟脗露SCHE, WOLFGANG and HEPTINSTALL, STAN, 2004. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist. Platelets. 14(7-8), 473-80
MAY, J. A. and HEPTINSTALL, S., 2004. Effects of Anticoagulants Used During Blood Collection on Human Platelet Function Methods in Molecular Biology. VOL 272, 3-12
MAY, JANE A and HEPTINSTALL, STANLEY, 2004. Effects of anticoagulants used during blood collection on human platelet function. Methods in Molecular Biology. 272, 3-11
ZHAO, L., BATH, P. M. W., FOX, S., MAY, J., JUDGE, H., LOSCHE, W. and HEPTINSTALL, S., 2003. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions Current Medical Research and Opinion. VOL 19(PART 3), 178-186 STAFFORD, N.P., PINK, A.E., WHITE, A.E., GLENN, J.R. and HEPTINSTALL, S., 2003. Arteriosclerosis, Thrombosis, and Vascular Biology. 23(10), 1928-1933
EVANS, P.A., HEPTINSTALL, S., CROWHURST, E.C., DAVIES, T., GLENN, J.R., MADIRA, W., DAVIDSON, S.J., BURMAN, J.F., HOSKINSON, J. and STRAY, C.M., 2003. Journal of Thrombosis and Haemostasis. 1(10), 2140-8
ZHAO, LIAN, BATH, PHILIP M W, FOX, SUE, MAY, JANE, JUDGE, HEATHER, L脰SCHE, WOLFGANG and HEPTINSTALL, STAN, 2003. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current Medical Research and Opinion. 19(3), 178-86
EVANS, P A, CROWHURST, E C, GLENN, J A, DAVIES, T and HEPTINSTALL, S, 2003. Platelets. 14(4), 253-7
FOX SC, JUDGE HM, ALLEN BR and HEPTINSTALL, S., 2002. Platelets. 13(4), 213-218
SCHOLZ, THOMAS, ZHAO, LIAN, TEMMLER, UTA, BATH, PHILIP, HEPTINSTALL, STAN and L脙露SCHE, WOLFGANG, 2002. Platelets. 13(7), 401-6
STOREY, R. F., JUDGE, H. M., WILCOX, R. G. and HEPTINSTALL, S., 2002. Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y~1~2 Receptor Antagonist AR-C69931MX but not Aspirin Thrombosis and Haemostasis. VOL 88(PART 3), 488-494
STOREY, ROBERT F, WILCOX, ROBERT G and HEPTINSTALL, STAN, 2002. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease. Platelets. 13(7), 407-13
STOREY, R. F., WILCOX, R. G. and HEPTINSTALL, S., 2002. Platelets. VOL 13(PART 7), 407-414
SCHOLZ, THOMAS, TEMMLER, UTA, KRAUSE, SIEGFRIED, HEPTINSTALL, STAN and L脙露SCHE, WOLFGANG, 2002. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thrombosis and Haemostasis. 88(6), 1033-8
FOX, S. C., JUDGE, H. M., ALLEN, B. R. and HEPTINSTALL, S., 2002. Platelets. VOL 13(PART 4), 213-218
DAVIES, A R, JUDGE, H M, MAY, J A, GLENN, J R and HEPTINSTALL, S, 2002. Platelets. 13(4), 197-205
STOREY, ROBERT F, JUDGE, HEATHER M, WILCOX, ROBERT G and HEPTINSTALL, STAN, 2002. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thrombosis and Haemostasis. 88(3), 488-94
ZHAO, L, BATH, P and HEPTINSTALL, S, 2001. British Journal of Pharmacology. 134(2), 353-8
STOREY, R. F., NEWBY, L. J. and HEPTINSTALL, S., 2001. Platelets. VOL 12(PART 7), 443-447
STOREY, R F, NEWBY, L J and HEPTINSTALL, S, 2001. Platelets. 12(7), 443-7
STOREY, R F, SANDERSON, H M, WHITE, A E, MAY, J A, CAMERON, K E and HEPTINSTALL, S, 2000. British journal of haematology. 110(4), 925-34
STOREY, R. F., SANDERSON, H. M., WHITE, A. E., MAY, J. A., CAMERON, K. E. and HEPTINSTALL, S., 2000. British Journal of Haematology. VOL 110(PART 4), 925-934
NATARAJAN, P, MAY, J A, SANDERSON, H M, ZABE, M, SPANGENBERG, P and HEPTINSTALL, S, 2000. Platelets. 11(8), 467-76
STOREY, R F and HEPTINSTALL, S, 1999. Clinical and Laboratory Haematology. 21(5), 317-29
COLE, A T, HUDSON, N, LIEW, L C, MURRAY, F E, HAWKEY, C J and HEPTINSTALL, S, 1999. Alimentary Pharmacology and Therapeutics. 13(2), 187-93
TAYLOR, J E, PORTER, C, HEPTINSTALL, S, MCLAREN, M and BELCH, J J, 1999. Increased platelet activation in renal transplant patients. Platelets. 10(4), 223-7
STOREY, R F, MAY, J A, WILCOX, R G and HEPTINSTALL, S, 1999. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thrombosis and haemostasis. 82(4), 1307-11
BROWN, N, MAY, J A, WILCOX, R G, ALLAN, L M, WILSON, A M, KIFF, P S and HEPTINSTALL, S, 1999. British Journal of Clinical Pharmacology. 48(1), 57-62
STOREY, R. F., MAY, J. A., WILCOX, R. G. and HEPTINSTALL, S., 1999. A Whole Blood Assay of Inhibition of Platelet Aggregation by Glycoprotein IIb/IIIa Antagonists: Comparison with other Aggregation Methodologies Thrombosis and Haemostasis. VOL 82(NUMBER 4), 1307-1311
PEIRCE, N S, FORSTER, C D, HEPTINSTALL, S and MACDONALD, I A, 1999. Unexpected changes in the catecholamine content of platelets and plasma during exercise. Platelets. 10(5), 312-8
HEPTINSTALL S, WHITE AE, EDWARDS N, PASCOE J, SANDERSON HM, FOX SC and HENDERSON RA, 1998. British Journal of Haematology. 103(4), 1023-30
LOWE,K.C., EDWARDS,C.M. and HEPTINSTALL,S., 1998. Experimental Biology Online. 3(Supplement 1998 SEB Annual Meeting Abstracts of papers - York 22-27 March), A6.19
STOREY, R F, WILCOX, R G and HEPTINSTALL, S, 1998. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation (Baltimore). 98(16), 1616-21
SANDERSON, H M, FOX, S C, ROBBINS, R A, L脰SCHE, W, SPANGENBERG, P and HEPTINSTALL, S, 1998. Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets. 9(3-4), 245-50
GLENN, J R and HEPTINSTALL, S, 1998. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium. Thrombosis and Haemostasis. 80(2), 321-5
L脰SCHE, W, REDLICH, H, KRAUSE, S, HEPTINSTALL, S and SPANGENBERG, P, 1998. Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes. Platelets. 9(3-4), 219-21
VICKERS, J, L脰SCHE, W, D脰PEL, E, HEPTINSTALL, S, STEIN, G and SPANGENBERG, P, 1998. Measurement of platelet activation and adhesion to leukocytes during haemodialysis. Platelets. 9(3-4), 261-4
MAY, J A, RATAN, H, GLENN, J R, L脰SCHE, W, SPANGENBERG, P and HEPTINSTALL, S, 1998. GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets. 9(3-4), 227-32
EDWARDS, C M, HEPTINSTALL, S and LOWE, K C, 1998. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 26(5-6), 441-7
EVANS, P A, GLENN, J R, HEPTINSTALL, S and MADIRA, W, 1998. Effects of gelatin-based resuscitation fluids on platelet aggregation. British Journal of Anaesthesia. 81(2), 198-202
EDWARDS, C M, HEPTINSTALL, S and LOWE, K C, 1997. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 25(5), 493-9
EDWARDS, C M, LOWE, K C, HEPTINSTALL, S, LUCAS, P, TRABELSI, H and CAMBON, A, 1997. Novel fluoro-surfactants for perfluorochemical emulsification. Effects on aggregation of human platelets in vitro and possible applications as anti-thrombotic agents. Advances in Experimental Medicine and Biology. 428, 489-93
REDLICH, H, VICKERS, J, L脰SCHE, W, HEPTINSTALL, S, KEHREL, B and SPANGENBERG, P, 1997. Formation of platelet-leukocyte conjugates in whole blood. Platelets. 8(6), 419-25
EVANS, P A, MADIRA, W, RIYATT, M S, ERRINGTON, M and HEPTINSTALL, S, 1997. Changes in plasma ionised calcium within 24 hours of trauma in patients infused with the calcium containing colloid Haemaccel during fluid resuscitation. Journal of Accident and Emergency Medicine. 14(2), 73-5
MAY JA, HEPTINSTALL S, COLE AT and HAWKEY CJ, 1997. Thrombosis research. 88(2), 183-92
YUSUF, S W, SANDERSON, H, HEPTINSTALL, S, NURDEN, A T, WENHAM, P W and HOPKINSON, B R, 1996. Blood Coagulation and Fibrinolysis. 7(2), 266-9
EDWARDS, C M, MAY, J A, HEPTINSTALL, S and LOWE, K C, 1996. Thrombosis Research. 81(4), 511-2
MAY, J. A., HEPTINSTALL, S. and SPANGENBERG, P., 1996. Blood Coagulation and Fibrinolysis. VOL 7(NUMBER SUP//2), 221-224
HORN, E H, HARDY, E, COOPER, J, HEPTINSTALL, S and RUBIN, P C, 1996. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Thrombosis and Haemostasis. 75(2), 346-51
SANDERSON, H M, HEPTINSTALL, S, VICKERS, J and L脙露SCHE, W, 1996. Blood Coagulation and Fibrinolysis. 7(2), 245-8
L脙露SCHE, W, DRESSEL, M, KRAUSE, S, REDLICH, H, SPANGENBERG, P and HEPTINSTALL, S, 1996. Contact-induced modulation of neutrophil elastase secretion and phagocytic activity by platelets. Blood Coagulation and Fibrinolysis. 7(2), 210-3
MAY JA, HEPTINSTALL S and SPANGENBERG P, 1996. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 7(2), 221-4
GLENN JR, SPANGENBERG P and HEPTINSTALL S, 1996. Platelets. 7(1-2), 23-7
HEPTINSTALL S, 1996. Platelets. 7(1-2), 7-8
MAY JA, GLENN JR, SPANGENBERG P and HEPTINSTALL S, 1996. Platelets. 7(3), 159-68
HEPTINSTALL, S, GLENN, J R, L脙露SCHE, W and SPANGENBERG, P, 1995. Seminars in thrombosis and hemostasis.. 21(2), 137-45
ARMSTRONG, R, MAY, J A, L脙露SCHE, W and HEPTINSTALL, S, 1995. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood. Thrombosis and Haemostasis. 73(2), 297-303
HEPTINSTALL, S, MAY, J A, GLENN, J R, SANDERSON, H M, DICKINSON, J P and WILCOX, R G, 1995. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Thrombosis and Haemostasis. 74(5), 1310-5
HORN, E. H., COOPER, J. A., HARDY, E. and HEPTINSTALL, S., 1995. Clinical Science. VOL 89(NUMBER 1), 91
HORN EH, COOPER JA, HARDY E, HEPTINSTALL S and RUBIN PC, 1995. Clinical science (london, england : 1979). 89(1), 91-9
HARDY E, HEPTINSTALL S, RUBIN PC and HORN EH, 1995. Platelets. 6(6), 346-53
HARDY E, GLENN J, HEPTINSTALL S, RUBIN PC and HORN EH, 1995. Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP. Thrombosis and haemostasis. 74(4), 1132-7
LOUDEN KA, BROUGHTON PIPKIN F, HEPTINSTALL S, FOX SC, TUOHY P, O'CALLAGHAN C, MITCHELL JR and SYMONDS EM, 1994. British Journal of Obstetrics and Gynaecology. 101(3), 203-8
ANDREWS, R, MAY, J A, VICKERS, J and HEPTINSTALL, S, 1994. Inhibition of platelet aggregation by transdermal glyceryl trinitrate. British Heart Journal. 72(6), 575-9
HEPTINSTALL S, 1994. Platelets. 5(1), 1-2
FOX SC, KILBY MD, SANDERSON HM and HEPTINSTALL S, 1994. Platelets. 5(3), 139-44
GLENN J, SPANGENBERG P and HEPTINSTALL S, 1994. Platelets. 5(2), 84-9
LONSDALE, R. J., HEPTINSTALL, S., WESTBY, J. C. and BERRIDGE, D. C., 1993. A 糖心原创 of the Use of the Thromboxane A~2 Antagonist, Sulotroban, in Combination with Streptokinase for Local Thrombolysis in Patients with Recent Peripheral Arterial Occlusions: Clinical Effects, Platelet Function and Fibrinolytic Parameters Thrombosis and Haemostasis. VOL 69(NUMBER 2), 103
LONSDALE RJ, HEPTINSTALL S, WESTBY JC, BERRIDGE DC, WENHAM PW, HOPKINSON BR and MAKIN GS, 1993. A study of the use of the thromboxane a2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters. Thrombosis and haemostasis. 69(2), 103-11, 123
GROENEWEGEN, W A, KNIGHT, D W and HEPTINSTALL, S, 1992. Progress in the medicinal chemistry of the herb feverfew. Progress in medicinal chemistry.. 29, 217-38
MARLES, R J, KAMINSKI, J, ARNASON, J T, PAZOS-SANOU, L, HEPTINSTALL, S, FISCHER, N H, CROMPTON, C W, KINDACK, D G and AWANG, D V, 1992. Journal of natural products.. 55(8), 1044-56
HEPTINSTALL, S, GLENN, J and SPANGENBERG, P, 1992. Changes in G-actin after platelet activation in platelet rich plasma. Thrombosis and Haemostasis. 68(6), 727-30
LOUDEN, K A, BROUGHTON PIPKIN, F, SYMONDS, E M, TUOHY, P, O'CALLAGHAN, C, HEPTINSTALL, S, FOX, S and MITCHELL, J R, 1992. British Journal of Obstetrics and Gynaecology. 99(5), 371-6
HEPTINSTALL, S, AWANG, D V, DAWSON, B A, KINDACK, D, KNIGHT, D W and MAY, J, 1992. Journal of Pharmacy and Pharmacology. 44(5), 391-5
LOUDEN KA, BROUGHTON PIPKIN F, HEPTINSTALL S, FOX SC, MITCHELL JR and SYMONDS EM, 1991. British Journal of Obstetrics and Gynaecology. 98(12), 1239-44
L脙露SCHE, W, VICKERS, J, MAY, J and HEPTINSTALL, S, 1991. Thrombosis Research. 61(2), 175-7
GRAY, S J and HEPTINSTALL, S, 1991. European Journal of Pharmacology. 194(1), 63-70
SPANGENBERG, P, HEPTINSTALL, S, CRAWFORD, J and TILL, U, 1991. Measurements of the G-/F-actin equilibrium in ADP-stimulated human platelets. Acta histochemica. Supplementband.. 41, 181-6
HORN, E H, COOPER, J, HARDY, E, HEPTINSTALL, S and RUBIN, P C, 1991. Clinical Science. 80(6), 549-58
LOUDEN KA, BROUGHTON PIPKIN F, HEPTINSTALL S, FOX SC, MITCHELL JR and SYMONDS EM, 1990. British Journal of Obstetrics and Gynaecology. 97(12), 1108-14
MAY, J, LOESCHE, W and HEPTINSTALL, S, 1990. Thrombosis Research. 59(3), 489-95
KILBY, M D, BROUGHTON PIPKIN, F, COCKBILL, S, HEPTINSTALL, S and SYMONDS, E M, 1990. Clinical Science. 78(1), 75-80
GROENEWEGEN, W A and HEPTINSTALL, S, 1990. Journal of Pharmacy and Pharmacology. 42(8), 553-7
KRAUSE, S, ARESE, P, HEPTINSTALL, S and L脙露SCHE, W, 1990. Influence of substances affecting cell sulfhydryl/disulfide status on adherence of human monocytes. Arzneimittel-Forschung.. 40(6), 689-92
PATTRICK, M, HEPTINSTALL, S and DOHERTY, M, 1989. Annals of the Rheumatic Diseases. 48(7), 547-9
GLUSA, E, BEVAN, J and HEPTINSTALL, S, 1989. Thrombosis Research. 55(2), 239-245
TILL, U, BERGMANN, I, BREDDIN, K, HEPTINSTALL, S, L脙露SCHE, W, MAZUROV, A and PESCARMONA, G, 1989. Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention? Progress in clinical and biological research.. 301, 341-5
L脙露SCHE, W, MICHEL, E, LULL, K, KREUTZFELD, B, HEPTINSTALL, S and TILL, U, 1989. [The effect of high glucose concentrations on the osmotic and mechanical resistance of human erythrocytes] Zeitschrift f脙录r medizinische Laboratoriumsdiagnostik.. 30(2), 124-7
KRAUSE, S, MICHEL, E, BRACHMANN, P, L脙露SCHE, W, HEPTINSTALL, S and TILL, U, 1989. [Cellular chemiluminescence of activated phagocytes of whole blood] Folia haematologica (Leipzig, Germany : 1928). 116(6), 955-65
HEPTINSTALL, S, COCKBILL, S R, BURGESS-WILSON, M E and JONES, E W, 1988. Studies on platelets before and after stroke in a patient with essential thrombocythaemia. British medical journal (Clinical research ed.). 296(6632), 1298-9
COCKBILL, S R, BURMESTER, H B and HEPTINSTALL, S, 1988. Pseudo grey platelet syndrome--grey platelets due to degranulation in blood collected into EDTA. European Journal of Haematology. 41(4), 326-33
LOESCHE, W, MAZUROV, A V, VOYNO-YASENETSKAYA, T A, GROENEWEGEN, W A, HEPTINSTALL, S and REPIN, V S, 1988. Feverfew--an antithrombotic drug? Folia haematologica (Leipzig, Germany : 1928). 115(1-2), 181-4
LOESCHE, W, GROENEWEGEN, W A, KRAUSE, S, SPANGENBERG, P and HEPTINSTALL, S, 1988. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets. Biomedica biochimica acta.. 47(10-11), S241-3
VOYNO-YASENETSKAYA, T A, LOESCHE, W, GROENEWEGEN, W A, HEPTINSTALL, S, REPIN, V S and TILL, U, 1988. Journal of Pharmacy and Pharmacology. 40(7), 501-2
MURPHY, J J, HEPTINSTALL, S and MITCHELL, J R, 1988. Lancet. 2(8604), 189-92
HEPTINSTALL, S, GROENEWEGEN, W A, SPANGENBERG, P and L脙露SCHE, W, 1988. Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia haematologica (Leipzig, Germany : 1928). 115(4), 447-9
L脙露SCHE, W, BEVAN, J, MICHEL, E, HEPTINSTALL, S and TILL, U, 1988. [Effect of high glucose concentrations on spontaneous aggregation of human blood platelets] Zeitschrift f脙录r medizinische Laboratoriumsdiagnostik.. 29(1), 55-8
HEPTINSTALL, S and BEVAN, J, 1988. How can we inhibit 5-HT-induced platelet aggregation and why should we bother? Folia haematologica (Leipzig, Germany : 1928). 115(4), 475-8
JOHNSTON, G.I. and HEPTINSTALL, S., 1988. Thrombosis and Haemostasis. 59, 54-61
L脙露SCHE, W, MICHEL, E, HEPTINSTALL, S, KRAUSE, S, GROENEWEGEN, W A, PESCARMONA, G P and THIELMANN, K, 1988. Planta medica.. 54(5), 381-4
HEPTINSTALL, S, 1988. Feverfew--an ancient remedy for modern times? Journal of The Royal Society of Medicine. 81(7), 373-4
BURGESS-WILSON, M E, COCKBILL, S R, JOHNSTON, G I and HEPTINSTALL, S, 1987. Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia. Blood. 69(1), 38-42
HEPTINSTALL, S, GROENEWEGEN, W A, SPANGENBERG, P and LOESCHE, W, 1987. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. Journal of Pharmacy and Pharmacology. 39(6), 459-65
HEPTINSTALL, S, 1987. Haematology, ethnography, and thrombosis. British medical journal (Clinical research ed.). 294(6563), 3-4
BURGESS-WILSON, M.E., COCKBILL, S.R., JOHNSTON, G.I. and HEPTINSTALL, S., 1987. Blood. 69, 38-42
L脙露SCHE, W, MAZUROV, A V, HEPTINSTALL, S, GROENEWEGEN, W A, REPIN, V S and TILL, U, 1987. Thrombosis Research. 48(5), 511-8
MAURICE, P D, ALLEN, B R, HEPTINSTALL, S and BATHER, P C, 1986. British Journal of Dermatology. 114(5), 553-66
BEVAN, J and HEPTINSTALL, S, 1986. Naunyn-Schmiedeberg's Archives of Pharmacology. 334(4), 341-5
BURGESS-WILSON, M E, MORRISON, R and HEPTINSTALL, S, 1986. Thrombosis Research. 41(3), 385-93
SILLS, T, COWLEY, A J and HEPTINSTALL, S, 1986. Thrombosis Research. 42(1), 91-8
SILLS, T and HEPTINSTALL, S, 1986. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour. Thrombosis and Haemostasis. 55(3), 305-8
PEACOCK, I, HAWKINS, M and HEPTINSTALL, S, 1986. Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control. Thrombosis and Haemostasis. 55(3), 361-5
GROENEWEGEN, W A, KNIGHT, D W and HEPTINSTALL, S, 1986. Journal of Pharmacy and Pharmacology. 38(9), 709-12
HEPTINSTALL, S, FOX, S, CRAWFORD, J and HAWKINS, M, 1986. Thrombosis Research. 42(2), 215-23
GROENEWEGEN, W A and HEPTINSTALL, S, 1986. Lancet. 1(8471), 44-5
BEVAN, J and HEPTINSTALL, S, 1985. Thrombosis Research. 38(2), 189-94
MORRISON, R, CRAWFORD, J, MACPHERSON, M and HEPTINSTALL, S, 1985. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thrombosis and Haemostasis. 54(3), 607-11
HEPTINSTALL, S, WHITE, A, WILLIAMSON, L and MITCHELL, J R, 1985. Lancet. 1(8437), 1071-4
COWLEY, A J, JONES, E W, CARTER, A J, HANLEY, S P and HEPTINSTALL, S, 1985. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals. British Journal of Clinical Pharmacology. 19(1), 1-8
ANDREWS, N P, BROUGHTON PIPKIN, F and HEPTINSTALL, S, 1985. Blood platelet behaviour in mothers and neonates. Thrombosis and Haemostasis. 53(3), 428-32
CARTER, A J and HEPTINSTALL, S, 1985. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate. Thrombosis and Haemostasis. 54(3), 612-6
GRAY, S J and HEPTINSTALL, S, 1985. European Journal of Pharmacology. 114(2), 129-37
JOHNSTON, G I, HEPTINSTALL, S and L脙露SCHE, W, 1985. Biochemical and Biophysical Research Communications. 127(3), 822-7
COWLEY, A J, HEPTINSTALL, S and MITCHELL, J R, 1985. Lancet. 2(8447), 154-5
L脙露SCHE, W, BURGESS-WILSON, M, MICHEL, E, HEPTINSTALL, S and TILL, U, 1985. Thrombosis Research. 40(6), 869-74
COWLEY, A J, HEPTINSTALL, S and HAMPTON, J R, 1985. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man. Thrombosis and Haemostasis. 53(1), 90-4
JOHNSTON, G I, HEPTINSTALL, S, ROBINS, R A and PRICE, M R, 1984. Biochemical and Biophysical Research Communications. 123(3), 1091-8
COWLEY, A J, STAINER, K, COCKBILL, S and HEPTINSTALL, S, 1984. Clinical Science. 67(5), 511-4
HEPTINSTALL, S, 1984. Properties of blood platelets that may be relevant to atherogenesis. VASA. Zeitschrift f脙录r Gef脙陇sskrankheiten. Journal for vascular diseases.. 13(4), 343-9
BURGESS-WILSON, M E, GREEN, S, HEPTINSTALL, S and MITCHELL, J R, 1984. Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit. Lancet. 2(8413), 1213
HEPTINSTALL S and FOX SC, 1983. British Journal of Clinical Pharmacology. 15 Suppl 1, 31S-37S
JONES, E W, COCKBILL, S R, COWLEY, A J, HANLEY, S P and HEPTINSTALL, S, 1983. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man. British Journal of Clinical Pharmacology. 15 Suppl 1, 39S-44S
BEVAN, J and HEPTINSTALL, S, 1983. Thrombosis Research. 30(5), 415-23
MULLEY, G P, HEPTINSTALL, S, TAYLOR, P M and MITCHELL, J R, 1983. ADP-induced platelet release reaction in acute stroke. Thrombosis and Haemostasis. 50(2), 524-6
BILLETT, E, HANLEY, S, HEPTINSTALL, S and MAYER, R J, 1983. Diabetes. 32(2), 130-3
FOX SC, BURGESS-WILSON M, HEPTINSTALL S and MITCHELL JR, 1982. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thrombosis and Haemostasis. 48(3), 327-9
HANLEY, S P, BEVAN, J, COCKBILL, S R and HEPTINSTALL, S, 1982. A regimen for low-dose aspirin? British medical journal (Clinical research ed.). 285(6351), 1299-302
BURNHAM, W R, HEPTINSTALL, S, COCKBILL, S R and HARRISON, S, 1982. Postgraduate Medical Journal. 58(677), 152-5
HANLEY, S P, BEVAN, J, COCKBILL, S R and HEPTINSTALL, S, 1981. Lancet. 1(8227), 969-71
HEPTINSTALL, S, BEVAN, J, COCKBILL, S R, HANLEY, S P and PARRY, M J, 1980. Thrombosis Research. 20(2), 219-30
HEPTINSTALL, S, MULLEY, G P, TAYLOR, P M and MITCHELL, J R, 1980. Platelet-release reaction in myocardial infarction. British medical journal.. 280(6207), 80-1
TAYLOR, P M and HEPTINSTALL, S, 1980. The abilities of human blood platelets to bind extracellular calcium and to be aggregated by adenosine diphosphate are related. British Journal of Haematology. 46(1), 115-22
HEPTINSTALL, S, 1980. Platelet behaviour and vascular disease. Artery.. 8(5), 448-56
COCKBILL, S.R., HEPTINSTALL, S. and TAYLOR, P.M., 1979. British Journal of Pharmacology. 67, 73-78
HEPTINSTALL, S and TAYLOR, P M, 1979. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen. Thrombosis and Haemostasis. 42(2), 778-93
COCKBILL, S R and HEPTINSTALL, S, 1978. A method for estimating prostaglandin synthetase activity in blood platelets and the extent of its pharmacological inhibition [proceedings] Journal of Physiology. 276, 15P-16P
HEPTINSTALL, S and TAYLOR, P M, 1978. The influence of anticoagulants and extracellular divalent cations on blood platelet behaviour [proceedings] Journal of Physiology. 276, 25P-26P
WHITE, A M and HEPTINSTALL, S, 1978. Contribution of platelets to thrombus formation. British Medical Bulletin. 34(2), 123-8
TAYLOR, P M and HEPTINSTALL, S, 1978. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction. Thrombosis and Haemostasis. 39(2), 550-1
HEPTINSTALL, S and MULLEY, G P, 1977. British Journal of Haematology. 36(4), 565-71
HEPTINSTALL, S., 1976. Thrombosis and Haemostasis. 36, 208-220
ADAMS, J, HEPTINSTALL, S and MITCHELL, J R, 1975. A six-channel automated platelet aggregometer. Thrombosis et diathesis haemorrhagica.. 34(3), 821-4
ARCHIBALD, A R, BADDILEY, J and HEPTINSTALL, S, 1973. Biochimica et Biophysica Acta. 291(3), 629-34
ARCHIBALD, A R, BADDILEY, J, HECKELS, J E and HEPTINSTALL, S, 1971. Further studies on the glycerol teichoic acid of walls of Staphylococcus lactis I3. Location of the phosphodiester groups and their susceptibility to hydrolysis with alkali. Biochemical Journal. 125(1), 353-9
ARCHIBALD, A R and HEPTINSTALL, S, 1971. The teichoic acids of Micrococcus sp. 24. Biochemical Journal. 125(1), 361-3
HEPTINSTALL, S, ARCHIBALD, A R and BADDILEY, J, 1970. Nature. 225(5232), 519-21
ARCHIBALD, A R, BADDILEY, J and HEPTINSTALL, S, 1969. Biochemical Journal. 111(2), 245-6
ARCHIBALD, A R, BADDILEY, J, BUTTON, D, HEPTINSTALL, S and STAFFORD, G H, 1968. Nature. 219(156), 855-6